Safety, Tolerability, and PK of NBI-98854 in Hepatically Impaired Subjects
1 clinical trials · Condition
◉ Watch Safety, Tolerability, and PK of NBI-98854 in Hepatically Impaired Subjects
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, and Pharmacokinetics of a Single Dose of NBI-98854 in Subjects With Mild,Moderate, or Severe Hepatic Insufficiency (NCT01916993) | Neurocrine Biosciences | 2013-08-01 |
Track Safety, Tolerability, and PK of NBI-98854 in Hepatically Impaired Subjects automatically
Every clearance here is in the API, with alerts when new ones post.